WGB-79412-88787
2 vaccinations
2 coded responses
19 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 908 / CA
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Health check-in — day 0, dose 1Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to workAdult check-in
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-07
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-14
- 2021-01-15
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-19
- 2021-01-20
-
2021-01-21
Health check-in — day 7, dose 2Feeling: Fair · Fever · Chills, Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-01-28
- 2021-02-06
- 2021-02-11
- 2021-02-18
- 2021-02-25
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid +MedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-17
-
2022-01-20
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-28 | priority 2/3 | |
| 2022-01-14 | Successful 2022-01-20 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Release 10 — 12 months, dose 2
Symptoms: Covid +
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release